HUMAN ANTICHIMERIC ANTIBODY POSITIVE

This adverse event was reported 291 times

These drugs are most commonly taken by patients reporting HUMAN ANTICHIMERIC ANTIBODY POSITIVE:

# Drug Count
0 METHOTREXATE SODIUM 271
1 TOCILIZUMAB 271
2 ABATACEPT 270
3 ETANERCEPT 270
4 INFLIXIMAB 269
5 SULFASALAZINE 269
6 ADALIMUMAB 268
7 ANAKINRA 267
8 METHOTREXATE 255
9 PREDNISONE 255
See all common drugs associated with HUMAN ANTICHIMERIC ANTIBODY POSITIVE

HUMAN ANTICHIMERIC ANTIBODY POSITIVE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TRIAMCINOLONE HEXACETONIDE 116 0.5714
1 VACCINIA IMMUNE GLOBULIN (HUMAN) 1 0.1250
2 ANAKINRA 267 0.0249
3 TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05% 103 0.0114
4 TRIAMCINOLONE ACETONIDE 103 0.0053
5 SULFASALAZINE 269 0.0049
6 HUMAN IMMUNOGLOBULIN G 15 0.0049
7 TOCILIZUMAB 271 0.0038
8 ABATACEPT 270 0.0029
9 HYDROXYCHLOROQUINE SULFATE 149 0.0022
See all drugs enriched for association with HUMAN ANTICHIMERIC ANTIBODY POSITIVE

HUMAN ANTICHIMERIC ANTIBODY POSITIVE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-1 Receptor Antagonist [EPC] 267 0.0249
1 Human Immunoglobulin G [EPC] 16 0.0046
2 Interleukin-6 Receptor Antagonist [EPC] 271 0.0034
3 Aminosalicylate [EPC] 270 0.0031
4 Selective T Cell Costimulation Modulator [EPC] 270 0.0029
5 Folate Analog Metabolic Inhibitor [EPC] 255 0.0008
6 Tumor Necrosis Factor Blocker [EPC] 284 0.0004
7 Corticosteroid [EPC] 265 0.0003
8 Vitamin D [EPC] 48 0.0003
9 Vitamin C [EPC] 48 0.0002
See all drug classes enriched for association with HUMAN ANTICHIMERIC ANTIBODY POSITIVE